Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model

Chest

Volumn 129, Issue 6, 2006, Pages 1577-1583

  Zhu, Zhiwen ^a   Hawthorne, Michael L ^a   Guo, Yubiao ^a   Drake, Wonder ^a   Bilaceroglu, Semra ^a   Misra, Heather L ^a   Light, Richard W ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Empyema; Fibrinolytic; Human recombinant deoxyribonuclease; Pleural; Rabbit; Therapy; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; LACTATE DEHYDROGENASE; PLACEBO; STREPTODORNASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; HEMATOTHORAX; LEUKOCYTE COUNT; NONHUMAN; PASTEURELLA MULTOCIDA; PLEURA EMPYEMA; PLEURA FLUID; PRIORITY JOURNAL; RABBIT; SCORING SYSTEM; SEPSIS; STATISTICAL ANALYSIS;

EID: 33745141933     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.6.1577     Document Type: Article

References (27)

1. Light RW. Pleural diseases. Philadelphia, PA: Lippincott, Williams & Wilkins, 2001; 151-181
2. Hasley PB, Albaum MN, Li Y-H, et al. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med 1996; 156:2206-2212
3. Tillet WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of postpneumonic empyema. J Thorac Surg 1951; 21:275-297
4. Diacon AH, Theron J, Schuurmans MM, et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004; 170:49-54
5. Maskell NA, Davies CW, Nunn AJ, et al. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352:865-874
6. Cameron R, Davies H. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2004; 2:CD002312
7. Light RW, Nguyen T, Mulligan ME, et al. The in vitro efficacy of Varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 2000; 178:13-18
8. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 2000; 117:1728-1733
9. Simpson G, Roomes D, Reeves B. Successful treatment of empyema thoraces with human recombinant deoxyribonuclease. Thorax 2003; 58:365-366
10. Sasse SA, Causing LA, Mulligan ME, et al. Serial pleural fluid analysis in a new experimental model of empyema. Chest 1996; 109:1043-1048
11. Sasse S, Nguyen TK, Mulligan M, et al. The effects of early chest tube placement on empyema resolution. Chest 1997; 111:1679-1683
12. Light RW, Cheng DS, Lee YCG, et al. A single intrapleural injection of transforming growth factor β-2 produces an excellent pleurodesis in rabbits. Am J Respir Crit Care Med 2000; 162:98-104
13. Streptase [package insert]. King of Prussia, PA: Aventis Behring LLC, 2002
14. Activase full prescribing information. Available at: www. gene.com/gene/products/informtion/cardiovascular/activase/insert.jsp. Accessed January 1, 2005
15. Pettersen JA, Hudon ME, Hill MD. Intra-arterial thrombolysis in acute ischemic stroke: a review of pharmacologic approaches. Expert Rev Cardiovasc Ther 2004; 2:285-299
16. Lapchak PA. Development of thrombolytic therapy for stroke: a perspective. Expert Opin Investig Drugs 2002; 11:1623-1632
17. Crabbe SJ, Cloninger CC. Tissue plasminogen activator: a new thrombolytic agent. Clin Pharm 1987; 6:373-386
18. Figueredo VM, Amidon TM, Wolfe CL. Thrombolysis after acute myocardial infarction: who should be added to inclusion criteria? Postgrad Med 1994; 96:37-40
19. Guerra DR, Karha J, Gibson CM. Safety and efficacy of tenecteplase in acute myocardial infarction. Expert Opin Pharmacother 2003; 4:791-798
20. Stevens A, Tobias JD. Tissue plasminogen activator as a adjunctive therapy of empyema in a child. J Int Car Med 2001; 16:287-289
21. Bishop NB, Pon S, Ushay M, et al. Alteplase in the treatment of complicated parapneumonic effusion: a case report. Pediatrics 2003; 111:e188-e190
22. Ray RL, Berkenbosh JW, Russo P, et al. Tissue plasminogen activator as a adjunctive therapy of empyema in pediatric patients. J Int Car Med 2004; 19:44-50
23. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000; 118:1158-1171
24. Davies RJO, Traill ZC, Gleeson FV. Randomized controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997; 52:416-421
25. Bouros D, Schiza S, Patsourakis G, et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusion: a prospective, double-blind study. Am J Respir Crit Care Med 1997; 155:291-295
26. Tuncozgur B, Ustunsoy H, Sivrikoz MC, et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract 2001; 55:658-660
27. Heffner JE. Multicenter trials of treatment for empyema: after all these years. N Engl J Med 2005; 352:926-928